Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -12.65x is 92% above its 5-year average of -151.47x, near the high end of its 5-year range (-702.06x–5.27x).
75.35% above its 12-month average of -51.31x.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2025 (2025-09-30): 4.10x.
INTEREST COVERAGE RATIO
-12.65x
INTEREST COVERAGE RATIO AVG TTM
-51.31x
INTEREST COVERAGE RATIO AVG 3Y
-51.31x
INTEREST COVERAGE RATIO AVG 5Y
-151.47x
INTEREST COVERAGE RATIO AVG 10Y
-1.55x
INTEREST COVERAGE RATIO AVG 15Y
-11.33x
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+75.35%
CURRENT VS 3Y AVG
+75.35%
CURRENT VS 5Y AVG
+91.65%
CURRENT VS 10Y AVG
-717.09%
CURRENT VS 15Y AVG
-11.61%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.44x
median of 527 covered companies
CURRENT VS SECTOR MEDIAN
-96.43%
vs the sector median at left
NeuroOne Medical Technologies Corporation
Market Cap
$9.83M
Interest Coverage Ratio
-12.65x
TTM Avg
-51.31x
3Y Avg
-51.31x
5Y Avg
-151.47x
Market Cap
$9.86M
Interest Coverage Ratio
-54.10x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$9.71M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.06M
Interest Coverage Ratio
-129.91x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.06M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.13M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NeuroOne Medical Technologies Corporation (NMTC) | $9.83M | -12.65x | -51.31x | -51.31x | -151.47x |
| Valion Bio, Inc. (VBIO)vs › | $9.86M | -54.10x | N/A | N/A | N/A |
| MetaVia Inc. (MTVA)vs › | $9.75M | N/A | N/A | N/A | N/A |
| Satellos Bioscience Inc. (MSLE)vs › | $9.71M | N/A | N/A | N/A | N/A |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.06M | -129.91x | N/A | N/A | N/A |
| Senti Biosciences, Inc. (SNTI)vs › | $10.06M | N/A | N/A | N/A | N/A |
| Tvardi Therapeutics, Inc. (TVRD)vs › | $10.13M | N/A | N/A | N/A | N/A |
| Ainos, Inc. (AIMD)vs › | $9.50M | -19.65x | N/A | N/A | N/A |
| Lifeward Ltd. (LFWD)vs › | $10.21M | -57.26x | N/A | N/A | N/A |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $10.45M | N/A | N/A | N/A | N/A |
Interest Coverage
-12.7x
Debt/Equity
0.02
Current Ratio
2.84
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2025-09-30 | 4.10x |
| 2025-06-30 | -202.32x |
| 2024-12-31 | 5.27x |
| 2024-09-30 | -12.30x |
| 2020-12-31 | -702.06x |
| 2020-09-30 | -1.51x |
| 2020-06-30 | -0.34x |
| 2019-12-31 | -0.67x |
| 2019-03-31 | -74.08x |
| 2018-12-31 | -4.07x |
| 2018-06-30 | -3.85x |
| 2018-03-31 | -5.69x |
| 2017-12-31 | -5.24x |
| 2017-09-30 | -1.73x |
| 2017-06-30 | -2.54x |
| 2017-03-31 | -2.42x |
| 2016-12-31 | -2.19x |
| 2016-09-30 | -0.53x |
| 2016-03-31 | -1.03x |
| 2015-12-31 | -3.24x |
| 2015-09-30 | -0.64x |
| 2015-03-31 | -5.23x |
| 2014-03-31 | -10.81x |
| 2013-12-31 | -6.30x |
| 2013-09-30 | -11.80x |
| 2013-06-30 | -3.42x |
| 2013-03-31 | -9.24x |
| 2012-12-31 | -23.57x |
| 2012-09-30 | -96.55x |
| 2012-06-30 | -35.17x |
| 2012-03-31 | -100.35x |
| 2011-12-31 | -276.04x |
| 2011-09-30 | -79.35x |
| 2011-06-30 | -31.11x |
| 2011-03-31 | -222.07x |
